Mezlocillin pharmacokinetics in patients with normal and impaired renal functions

Antimicrob Agents Chemother. 1979 Nov;16(5):651-4. doi: 10.1128/AAC.16.5.651.

Abstract

The pharmacokinetics of intravenous bolus doses of 1.0 g of mezlocillin were studied in 13 persons with normal and reduced renal functions. In renal failure a moderate increase was observed for the terminal serum half-life(t1/2 beta). This changed from a mean of 1.1 h at a glomerular filtration rate of 100 ml/min to 1.6 h at 10 ml/min. The difference was not statistically significant. The excretion of unchanged drug in urine during 24 h was reduced from a mean of 59.4% (range, 52 to 77) in subjects with glomerular filtration rate above 50 ml/min to 10% (range, 7.9 to 12.1) in two patients with glomerular filtration rate of 10 to 20 ml/min. The volume of distribution during the beta-phase, Vd,b, was 14% of the body weight. Much of the antibiotic was metabolized, and this proportion increased upon reduction in renal function.

MeSH terms

  • Aged
  • Female
  • Glomerular Filtration Rate
  • Half-Life
  • Humans
  • Kidney Diseases / metabolism*
  • Kinetics
  • Male
  • Middle Aged
  • Penicillins / blood
  • Penicillins / metabolism*
  • Penicillins / urine

Substances

  • Penicillins